Number of rosuvastatin prescriptions in the U.S. 2004-2022

Published by
Matej Mikulic,
Nov 4, 2024

In 2022, a new record-high of over 37 million prescriptions for rosuvastatin were issued in the United States. Rosuvastatin is used in combination with exercise, diet, and weight-loss to treat high cholesterol and related conditions, and to prevent cardiovascular disease. This statistic shows the total annual number of rosuvastatin calcium prescriptions in the U.S. from 2004 to 2022, in millions.

Number of rosuvastatin prescriptions in the U.S. from 2004 to 2022 (in millions)

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

2024

Region

United States

Survey time period

2004 to 2022

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical products: Crestor (rosuvastatin) and Nexium (esomeprazole) "

The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical products: Crestor (rosuvastatin) and Nexium (esomeprazole)

Overview

8

Consumer behavior and drug prices

5

Advertising expenditures

3

Further related statistics

20

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in RomaniaSanofiBiotechnology in SpainBiotech drugsPfizer
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.